Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Claudia Sheinbaum Delivers First Government Report U.S. and Mexico Form High-Level Security Task Force California Fugitive Captured in Jalisco Transferred to U.S. Authorities Mexican Postal Service Halts Shipments to U.S. after Tax Rule Change Mexican Drug Lord ‘El Mayo’ Zambada Pleads Guilty in U.S. to Trafficking Charges
